Business Context and Reporting Period
Company: uniQure N.V.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: November 30, 2015
Reporting Period: Nine months ended September 30, 2015
Context: This filing serves as a cover document to furnish unaudited consolidated financial results and statements for the nine-month period. The primary financial data is contained in the attached exhibits (Exhibit 99.1 Press Release and Exhibit 99.2 Financial Statements/MD&A), which are referenced but not included in the text of this Form 6-K.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 and Exhibit 99.2) referenced in the filing.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Such analysis is located in the Management's Discussion and Analysis (MD&A) provided in Exhibit 99.2.
Guidance, Outlook, and Risks
This Form 6-K does not contain management commentary, guidance, outlook, or specific risk factors. These disclosures are expected to be found in the press release (Exhibit 99.1) and the MD&A (Exhibit 99.2) attached to this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific unaudited financial results for the nine months ended September 30, 2015.
- Examine Exhibit 99.2 for the full unaudited consolidated financial statements and Management's Discussion and Analysis.
- Verify the company's cash position and burn rate, as the filing indicates the company is in a development phase (implied by the nature of the exhibits) but does not state the figures in the cover text.
- Confirm the status of the company's clinical programs and regulatory milestones, which are typically detailed in the press release and MD&A.